No Detail Found!

The cardiovascular phenotype: impact on choice of glucose- lowering therapy.

Author(s)
Sanjay Kalra Department of Endocrinology, Bharti Hospital, Karnal, India
Yashdeep Gupta Department of Endocrinology, AIIMS, New Delhi, India
Kamal Kishor Department of Cardiology, Cygnus Hospital, Karnal, India
Abstract
One of the major endpointsto be considered while choosing glucose-lowering therapy is their impact on cardiovascular outcomes. As a corollary, the cardiovascular health assessment of a person with diabetes informs the choice of glucose-lowering treatment. The clinical aspects included in this bidirectional relationship are described in this review as the cardiovascular phenotype. Vital signs, cardiac autonomic function, myocardial health and coronary status influence, and are influenced by, choice of glucose-lowering therapy. Such therapy also has an impact on cerebrovascular and peripheral arterialhealth.These aspectsshouldbe considered while planning treatment for type 2 diabetes mellitus.
Publication Details
Page(s) 480-482
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 66, Issue: 4, Year: 2016

Request the full text from PASTIC

0

Citations

0

Downloads

83

Views